<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
MEDIMMUNE, INC.
- -------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, Par Value $0.01 per share
- -------------------------------------------------------------------------------
(Title of Class of Securities)
584699102
-------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP NO. 584699102 13G Page 2 of 6 Pages
1. NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Reliance Financial Services Corporation
I.R.S. Employer Identification No.: 51-0113548
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
5. SOLE VOTING POWER
1,191,130 (See Note l)
NUMBER OF SHARES
6. SHARED VOTING POWER
BENEFICIALLY OWNED
BY EACH REPORTING
7. SOLE DISPOSITIVE POWER
PERSON WITH
1,191,130 (See Note l)
8. SHARED DISPOSITIVE POWER
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,191,130 (See Note l)
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.4% (See Note l)
12. TYPE OF REPORTING PERSON*
HC
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Item 1(a) Name of Issuer:
MedImmune, Inc.
.............................................................
Item 1(b) Address of Issuer's Principal Executive Offices:
35 West Watkins Mill Road, Gaithersburg, MD 20878
.............................................................
Item 2(a) Name of Person Filing:
Reliance Financial Services Corporation
.............................................................
Item 2(b) Address of Principal Business Office or, if none, Residence:
Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055
.............................................................
Item 2(c) Citizenship:
Delaware
.............................................................
Item 2(d) Title of Class of Securities:
Common Stock, Par Value $0.01
.............................................................
Item 2(e) CUSIP Number:
584699102
.............................................................
Item 3 (g) [X ] Parent Holding Company, in accordance with
Section 240.13d-1(b)(ii)(G)
Item 4. Ownership.
(a) Amount Beneficially Owned As of December 3l, l996
1,191,130 (See Note l)
.............................................................
(b) Percent of Class:
5.4% (See Note l)
.............................................................
<PAGE>
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
1,191,130 (See Note l)
.............................................................
(ii) shared power to vote or to direct the vote
-0-
.............................................................
(iii) sole power to dispose or to direct the
disposition of
1,191,130 (See Note l)
.............................................................
(iv) shared power to dispose or to direct the
disposition of
-0-
.............................................................
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
.............................................................
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not Applicable
.............................................................
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security Being Reported on By the Parent Holding
Company.
Reliance Insurance Company
.............................................................
Item 8. Identification and Classification of Members of the Group.
Not Applicable
.............................................................
Item 9. Notice of Dissolution of Group.
Not Applicable
.............................................................
<PAGE>
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in
the ordinary course of business and were not acquired for the
purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
February 13, 1997 as of December 31, 1996
.............................................................
Date
RELIANCE FINANCIAL SERVICES CORPORATION
By:/s/ James E. Yacobucci
-----------------------------------------------
James E. Yacobucci
Senior Vice President-Investments
<PAGE>
Note 1. Reliance Insurance Company ("RIC") beneficially owns $10,000,000
principal amount of 7% Convertible Subordinated Notes due 2003 of MedImmune,
Inc. (the "Notes"), each of which is convertible (in denominations of $1,000 or
multiples thereof) into 50.813 shares of Common Stock. Upon conversion, the
Notes will total 508,130 shares of Common Stock. RIC also beneficially owns
683,000 shares of Common Stock. The Securities beneficially owned by RIC
(assuming conversion of the Notes) total 1,191,130 shares of Common Stock and
represent 5.4% of the Securities outstanding.
